Content area

|
|

Reduceret risiko for diabetes og kardiovaskulær sygdom efter fedmekirurgi

Forfatter(e)
Ida Kirstine Bull Rasmussen1, Søren Sandager Petersen2, Jacob Juel3, Morten Rix Hansen4, 5, Niels Holmark Andersen6 & Manan Pareek2, 7, 8 1) Medicinsk Afdeling, Sjællands Universitetshospital, Roskilde 2) Endokrinologisk Afdeling, Odense Universitetshospital 3) Plastikkirurgisk Afdeling, Aalborg Universitetshospital 4) Klinisk Farmakologi og Farmaci, Det Sundhedsviden-skabelige Fakultet, Syddansk Universitet 5) Afdeling for Klinisk Biokemi og Farmakologi, Odense Universitetshospital 6) Kardiologisk Afdeling, Aalborg Universitetshospital 7) Brigham and Women’s Hospital Heart & Vascular Center, Harvard Medical School 8) Medicinsk Afdeling, Holbæk Sygehus Ugeskr Læger 2018;180:V10170782
Reference: 
Ugeskr Læger 2018;180:V10170782
Sidetal: 
2-7
Reduced risk of diabetes and cardiovascular disease after bariatric surgery
The worldwide incidence of obesity, defined as a BMI ≥ 30 kg/m2, has more than doubled during the past four decades. Bariatric/metabolic surgery provides the largest and most sustainable degree of weight loss. This review briefly summarises the emerging randomised evidence of the superiority of these procedures over conventional treatment, in achieving glycaemic control and inducing remission in patients with type 2 diabetes as well as the observational evidence suggesting improvements in the long-term risks of cardiovascular outcomes and mortality.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Jens Enné Sletgaard | 20/09
3 kommentarer
af Alice Kunkel | 17/09
7 kommentarer
af Jørn Rosborg | 17/09
1 Kommentar
af Peter Christian Gøtzsche | 17/09
1 Kommentar
af Jens Ole Mathiesen | 16/09
3 kommentarer
af Annette Randløv | 16/09
2 kommentarer
af Jens Ole Mathiesen | 15/09
4 kommentarer
af Jens Ole Mathiesen | 14/09
4 kommentarer
af Steffen Thirstrup | 11/09
4 kommentarer